KTX-951, a PROTAC designed for IRAK4 degradation (DC 50 =18 nM), exhibits an oral bioavailability (F%) of 22% in a rat model at a dosage of 10 mg/kg. Additionally, KTX-951 demonstrates promising anticancer potential [1].
Molecular Weight:
850.95
CAS Number:
[2573298-36-7]
Formula:
C46H52F2N8O6
* VAT and and shipping costs not included. Errors and price changes excepted